CytomX Therapeutics CTMX
NASDAQ CTMX
$2.75 +0.06 (+2.23%)
At close: Sep 29, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Operating Expenses (2014 - 2026)

Updated

CytomX Therapeutics' Operating Expenses was $25.2 million in Q2 2026, up 26.3% from $19.94 million a year earlier but down 15.8% from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) Operating Expenses (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, CytomX Therapeutics' Operating Expenses was $105.46 million through Jun 30, 2026, up 7.6% year-over-year; for FY2025, it was $98.57 million, down 12.9% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of -7.9% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $113.11 million in FY2024 (+5.0%), $107.7 million in FY2023 (-30.3%), $154.5 million in FY2022 (+0.7%) and $153.35 million in FY2021 (+2.9%).
  • Quarterly Operating Expenses has moved between $19.94 million (Q2 2025) and $46.04 million (Q4 2021) over five years.
  • Compared with a year earlier, Operating Expenses has increased for three straight quarters, with growth averaging 0.2% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2021 (growth of 47.8%); the worst was Q3 2023 (a decline of 43.1%).
  • Per Business Quant data, CTMX's Operating Expenses in the three quarters before Q2 2026 was $29.93 million (Q1 2026), $28.6 million (Q4 2025) and $21.73 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 CytomX Therapeutics 586.15 Mn -371.52 Mn - 25.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.20 Mn
Mar 31, 2026 29.93 Mn
Dec 31, 2025 28.60 Mn
Sep 30, 2025 21.73 Mn
Jun 30, 2025 19.94 Mn
Mar 31, 2025 28.30 Mn
Dec 31, 2024 20.41 Mn
Sep 30, 2024 29.32 Mn
Jun 30, 2024 33.57 Mn
Mar 31, 2024 29.81 Mn
Dec 31, 2023 27.21 Mn
Sep 30, 2023 23.26 Mn
Jun 30, 2023 28.07 Mn
Mar 31, 2023 29.15 Mn
Dec 31, 2022 29.63 Mn
Sep 30, 2022 40.86 Mn
Jun 30, 2022 42.91 Mn
Mar 31, 2022 41.10 Mn
Dec 31, 2021 46.04 Mn
Sep 30, 2021 40.23 Mn
API Access

CytomX Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CTMX&period=max&api_key=YOUR_API_KEY